Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-008070

Chief Medical Officer acquired 17,231 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Detke Michael J. Chief Medical Officer 2020-02-07 Option exercise +17,231 $6.91 $119,066 17,231 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Detke Michael J. Chief Medical Officer 2020-02-06 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D: show line 2 in the form
Detke Michael J. Chief Medical Officer 2020-02-07 Option exercise · Stock Option (Right to Buy) −17,231 115,121 D: show line 3 in the form
Loading xslF345X03/doc4.xml…